90 related articles for article (PubMed ID: 12231529)
1. Expansion of microsatellite in the thyroid hormone receptor-alpha1 gene linked to increased receptor expression and less aggressive thyroid cancer.
Onda M; Li D; Suzuki S; Nakamura I; Takenoshita S; Brogren CH; Stampanoni S; Rampino N
Clin Cancer Res; 2002 Sep; 8(9):2870-4. PubMed ID: 12231529
[TBL] [Abstract][Full Text] [Related]
2. Microsatellite instability in thyroid cancer: hot spots, clinicopathological implications, and prognostic significance.
Onda M; Nakamura I; Suzuki S; Takenoshita S; Brogren CH; Stampanoni S; Li D; Rampino N
Clin Cancer Res; 2001 Nov; 7(11):3444-9. PubMed ID: 11705861
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
[TBL] [Abstract][Full Text] [Related]
5. Thyroid cancer susceptibility and THRA1 and BAT-40 repeats polymorphisms.
Baida A; Farrington SM; Galofré P; Marcos R; Velázquez A
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):638-42. PubMed ID: 15767343
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological roles of alterations of tumor suppressor gene p16 in papillary thyroid carcinoma.
Lam AK; Lo CY; Leung P; Lang BH; Chan WF; Luk JM
Ann Surg Oncol; 2007 May; 14(5):1772-9. PubMed ID: 17195959
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
[TBL] [Abstract][Full Text] [Related]
8. c-Met expression in tall cell variant papillary carcinoma of the thyroid.
Nardone HC; Ziober AF; LiVolsi VA; Mandel SJ; Baloch ZW; Weber RS; Mick R; Ziober BL
Cancer; 2003 Oct; 98(7):1386-93. PubMed ID: 14508824
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
[TBL] [Abstract][Full Text] [Related]
10. Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness.
Ulivieri A; Lavra L; Dominici R; Giacomelli L; Brunetti E; Sciacca L; Trovato M; Barresi G; Foukakis T; Jia-Jing L; Larsson C; Bartolazzi A; Sciacchitano S
J Pathol; 2008 May; 215(1):87-96. PubMed ID: 18306168
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
[TBL] [Abstract][Full Text] [Related]
12. Expression of thyroid hormone receptor/erbA genes is altered in human breast cancer.
Silva JM; Domínguez G; González-Sancho JM; García JM; Silva J; García-Andrade C; Navarro A; Muñoz A; Bonilla F
Oncogene; 2002 Jun; 21(27):4307-16. PubMed ID: 12082618
[TBL] [Abstract][Full Text] [Related]
13. Genetic mutations in thyroid carcinoma.
Taccaliti A; Boscaro M
Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
[TBL] [Abstract][Full Text] [Related]
14. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite instability in thyroid tumours and tumour-like lesions.
Lazzereschi D; Palmirotta R; Ranieri A; Ottini L; Verì MC; Cama A; Cetta F; Nardi F; Colletta G; Mariani-Costantini R
Br J Cancer; 1999 Jan; 79(2):340-5. PubMed ID: 9888478
[TBL] [Abstract][Full Text] [Related]
16. COX-2 is induced by HGF stimulation in Met-positive thyroid papillary carcinoma cells and is involved in tumour invasiveness.
Scarpino S; Duranti E; Stoppacciaro A; Pilozzi E; Natoli G; Sciacchitano S; Luciani E; Ruco L
J Pathol; 2009 Aug; 218(4):487-94. PubMed ID: 19391129
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in thyroid carcinomas.
Fonseca E; Soares P; Rossi S; Sobrinho-Simões M
Verh Dtsch Ges Pathol; 1997; 81():82-96. PubMed ID: 9474858
[TBL] [Abstract][Full Text] [Related]
18. Localization and expression of thyroid hormone receptors normal and neoplastic human thyroid.
Crescenzi A; Graziano MF; Carosa E; Papini E; Rucci N; Nardi F; Trimboli P; Calvanese A; Jannini EA; D'Armiento M
J Endocrinol Invest; 2003 Oct; 26(10):1008-12. PubMed ID: 14759075
[TBL] [Abstract][Full Text] [Related]
19. Molecular prognosticators and genomic instability in papillary thyroid cancer.
Rigual NR; Anderson GR; Loree TR; Wiseman S; Alrawi S; Stoler DL
Laryngoscope; 2005 Aug; 115(8):1479-85. PubMed ID: 16094129
[TBL] [Abstract][Full Text] [Related]
20. Methylation status of genes in papillary thyroid carcinoma.
Smith JA; Fan CY; Zou C; Bodenner D; Kokoska MS
Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1006-11. PubMed ID: 17938324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
